Auto-generated from public data. Not the firm's stated position.
Venturelab appears to focus on early-stage investments across healthcare and technology sectors, with a particular emphasis on digital health and therapeutic innovation. Based on disclosed data, the firm deploys check sizes between €0.1M and €1.5M across pre-seed through Series B stages, suggesting a strategy that spans foundational and growth-stage opportunities in edtech and fintech alongside life sciences applications.
Generated 18 Oct 2026 from disclosed sectors, stages, and portfolio companies. Firms can update this by emailing [email protected].
Auto-extracted from press releases.
Focus and check size from the firm's website. Website reachable as of Oct 2026.
A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.